Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Phibro Animal Health
PAHC
$1.46B
| $5.2M | 0.01% |
161,810
-16,139
| -9% | -$609K |
|
1552
Qorvo
QRVO
$8.39B
| $5.2M | 0.01% |
85,662
-225,615
| -72% | -$15.2M |
|
1553
The GEO Group
GEO
$4.31B
| $5.2M | 0.01% |
263,882
-481,729
| -65% | -$10.9M |
|
|
BMS
1554
DELISTED
Bemis
BMS
| $5.18M | 0.01% |
112,896
+52,157
| +86% | +$2.43M |
|
|
MINI
1555
DELISTED
Mobile Mini Inc
MINI
| $5.18M | 0.01% |
163,057
+120,702
| +285% | +$4.68M |
|
1556
Canadian National Railway
CNI
$77.1B
| $5.17M | 0.01% |
69,794
+5,929
| +9% | +$491K |
|
|
ENLC
1557
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.17M | 0.01% |
544,931
-409,964
| -43% | -$5.28M |
|
1558
Chemed
CHE
$7.17B
| $5.16M | 0.01% |
18,196
-61,084
| -77% | -$18.4M |
|
1559
PUT
Home Depot
HD
$334B
| $5.16M | 0.01% |
+30,000
| New | +$5.38M |
|
1560
PUT
Trinity Industries
TRN
$2.35B
| $5.15M | 0.01% |
+250,000
| New | +$5.76M |
|
|
CRAY
1561
DELISTED
Cray, Inc.
CRAY
| $5.12M | 0.01% |
237,062
+186,876
| +372% | +$4.23M |
|
|
NGHC
1562
DELISTED
National General Holdings Corp
NGHC
| $5.12M | 0.01% |
211,300
+81,583
| +63% | +$2.08M |
|
1563
The Ensign Group
ENSG
$10.5B
| $5.12M | 0.01% |
140,975
+124,612
| +762% | +$4.85M |
|
|
DMTK
1564
DELISTED
DermTech, Inc. Common Stock
DMTK
| $5.11M | 0.01% |
+250,000
| New | +$5.08M |
|
|
DX
1565
Dynex Capital
DX
$3.2B
| $5.11M | 0.01% |
297,519
+197,564
| +198% | +$3.54M |
|
|
NVRO
1566
CALL
DELISTED
NEVRO CORP.
NVRO
| $5.09M | 0.01% |
130,900
-59,100
| -31% | -$2.63M |
|
|
TBRGU
1567
DELISTED
Thunder Bridge Acquisition, Ltd. Unit
TBRGU
| $5.09M | 0.01% |
500,000
| – | – |
|
|
BZUN
1568
Baozun
BZUN
$164M
| $5.08M | 0.01% |
173,915
-60,995
| -26% | -$2.25M |
|
1569
CACI
CACI
$13.8B
| $5.08M | 0.01% |
35,245
+10,417
| +42% | +$1.77M |
|
|
PBPB
1570
DELISTED
Potbelly
PBPB
| $5.07M | 0.01% |
629,545
+310,119
| +97% | +$3.33M |
|
1571
Independent Bank Corp
IBCP
$815M
| $5.06M | 0.01% |
240,933
-33,025
| -12% | -$743K |
|
1572
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $5.06M | 0.01% |
+48,700
| New | +$5.09M |
|
|
EPZM
1573
DELISTED
Epizyme, Inc
EPZM
| $5.04M | 0.01% |
818,800
+687,047
| +521% | +$5.25M |
|
1574
Target Hospitality
TH
$1.67B
| $5.04M | 0.01% |
500,000
| – | – |
|
|
MFAC.U
1575
DELISTED
Megalith Financial Acquisition Corp. Units, each consisting of one share of Class A Common Stock, an
MFAC.U
| $5.04M | 0.01% |
500,000
| – | – |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.